Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis
Status:
Active, not recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, double-dummy, comparative study in parallel groups of
subjects presenting with recurrent cystitis (≥2 episodes within the past 6 months). Subjects
will be randomized and treated with one of two presentations of urinary antiseptics
containing methenamine and methylthioninium for three days, followed by three days of
antibiotic therapy as determined by urine culture and antibiogram. This study aims to assess
the efficacy and safety of each treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Fundação Educacional Serra dos Órgãos
Collaborator:
Laboratório Gross S.A.
Treatments:
Acriflavine Anti-Bacterial Agents Methenamine Methenamine hippurate Methenamine mandelate Methylene Blue